Pharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2019
DORADO, PUERTO RICO / ACCESSWIRE / September 16, 2019 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a...
Day: September 16, 2019
Champions Oncology Reports Quarterly Revenue of $6.7 Million
HACKENSACK, NJ / ACCESSWIRE / September 16, 2019 / Champions Oncology, Inc. (NASDAQ:CSBR), engaged in an end-to-end range of research...
FDA Clears ARTIS icono Family of Angiography Systems From Siemens Healthineers
ARTIS icono biplane system enables wide variety of neuroradiology and abdominal imaging procedures ARTIS icono floor single-plane system permits vascular,...
Integrated BioPharma Reports Results for its Fiscal Year Ended June 30, 2019
HILLSIDE, NJ / ACCESSWIRE / September 16, 2019 / Integrated BioPharma, Inc. (OTCQB:INBP) (the “Company” or “INBP”) reported financial results...
Dr. Narinder Grewal’s Involvement Helps Fund Completion of Henry Mayo Newhall Hospital’s New Patient Tower
With more than 20 years of work in the field of interventional pain management, Dr. Narinder Grewal is dedicated to...
Jaguar Health’s Mytesi Drug Product Now Approved for Sale in Puerto Rico
Puerto Rico Had the 7th Highest Cumulative Rate of HIV Infection in the Nation in 2016 SAN FRANCISCO, CA /...
Experion Engages Mackie Research Capital for Market Making Services
VANCOUVER, BC / ACCESSWIRE / September 16, 2019 / Experion Holdings Ltd. (TSXV: EXP) (OTCQB: EXPFF) (FRANKFURT: MB31), formerly Viridium...
MorphoSys’s Licensee Janssen Submits Biologics License Application to U.S. FDA of Tremfya(R) (Guselkumab) for Treatment of Adults with Active Psoriatic Arthritis
MorphoSys's Licensee Janssen Submits Biologics License Application to U.S. FDA of Tremfya(R) (Guselkumab) for Treatment of Adults with Active Psoriatic...
Theralase Grants Stock Options
TORONTO, ON / ACCESSWIRE / September 16, 2019 / Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV:TLT) (OTCQB:TLTFF), a clinical...
EyeGate Pharma Reaches 75% Randomization of Patients in Pivotal Study
WALTHAM, MA / ACCESSWIRE / September 16, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or “the Company”), a clinical-stage company...
AIM ImmunoTech Names Ellen Lintal as New Chief Financial Officer
OCALA, FL / ACCESSWIRE / September 16, 2019 / AIM ImmunoTech Inc. (NYSE American:AIM), an immuno-pharma company focused on the...
TM Robotics to exhibit at MD&M Minneapolis 2019
Industrial robot distributor, TM Robotics will exhibit its latest industrial automation packages at Medical Device & Manufacturing (MD&M) 2019, held in...
Medality Medical Commences Clinical Trial for Type 2 Diabetes
MIDLAND PARK, N.J.--(BUSINESS WIRE)--Medality Medical LLC (“Medality” or the “Company”), a U.S.-based medical technology company, announced that it has received...